Search

Interfacial atomic configuration plays a vital role in the structural stability and functionality of nanocomposites composed of metal nanoparticles (NPs) and two−dimensional semiconductors. In situ transmission electron microscope (TEM) provides a real−time technique to observe the interface structure at atomic resolution. Herein, we loaded bimetallic NiPt truncated octahedral NPs (TONPs) on MoS2 nanosheets and constructed a NiPt TONPs/MoS2 heterostructure. The interfacial structure evolution of NiPt TONPs on MoS2 was in situ investigated using aberration−corrected TEM. It was observed that some NiPt TONPs exhibited lattice matching with MoS2 and displayed remarkable stability under electron beam irradiation. Intriguingly, the rotation of an individual NiPt TONP can be triggered by the electron beam to match the MoS2 lattice underneath. Furthermore, the coalescence kinetics of NiPt TONPs can be quantitatively described by the relationship between neck radius (r) and time (t), expressed as rn = Kt. Our work offers a detailed analysis of the lattice alignment relationship of NiPt TONPs on MoS2, which may enlighten the design and preparation of stable bimetallic metal NPs/MoS2 heterostructures. [ABSTRACT FROM AUTHOR]

5a: The representative ALP staining images of Azo+si-glp-1r-1 and Azo+si-glp-1r-2 are the same The authors provided the raw data for validation. Retraction Note: Stem Cell Research & Therapy (2018) 9:57 https://doi.org/10.1186/s13287-... The Editors-in-Chief have retracted this article at the authors' request. Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA- -catenin pathway. [Extracted from the article]

Metal sulfides electrodeposition in sulfur cathodes mitigates the shuttle effect of polysulfides to achieve high Coulombic efficiency in secondary metal-sulfur batteries. However, fundamental understanding of metal sulfides electrodeposition and kinetics mechanism remains limited. Here using room-temperature sodium-sulfur cells as a model system, we report a Mo5N6 cathode material that enables efficient Na2S electrodeposition to achieve an initial discharge capacity of 512 mAh g−1 at a specific current of 1 675 mA g−1, and a final discharge capacity of 186 mAh g−1 after 10,000 cycles. Combined analyses from synchrotron-based spectroscopic characterizations, electrochemical kinetics measurements and density functional theory computations confirm that the high d-band position results in a low Na2S2 dissociation free energy for Mo5N6. This promotes Na2S electrodeposition, and thereby favours long-term cell cycling performance. Incomplete conversion of sodium polysulfides represents a significant issue in room-temperature sodium-sulfur batteries. Here, the authors propose Mo5N6 as an electrocatalyst for efficient Na2S electrodeposition and improved cell cycling performances. [ABSTRACT FROM AUTHOR]

Background: The reciprocal fate decision of mesenchymal stem cells (MSCs) to either bone or adipocytes is determined by Wnt-related signaling and the glucagon-like peptide-1 receptor (GLP-1R). Azoramide, an ER stress alleviator, was reported to have an antidiabetic effect. In this study, we investigated the function of azoramide in regulating the lineage determination of MSCs for either adipogenic or osteogenic differentiation. Methods: In this study, microcomputed tomography and histological analysis on bone morphogenetic protein (BMP)2-induced parietal periosteum bone formation assays, C3H10T1/2 and mouse bone marrow MSC-derived bone formation and adipogenesis assays, and specific staining for bone tissue and lipid droplets were used to evaluate the role of azoramide on the lineage determination of MSC differentiation. Cells were harvested for Western blot and quantitative real-time polymerase chain reaction (PCR), and immunofluorescence staining was used to explore the potential mechanism of azoramide for regulating MSC differentiation. Results: Based on MSC-derived bone formation assays both in vivo and in vitro, azoramide treatment displayed a cell fate determining ability in favor of adipogenesis over osteogenesis. Further mechanistic characterizations disclosed that both the GLP-1R agonist peptide exendin-4 (Ex-4) and GLP-1R small interfering (si)RNA abrogated azoramide dual effects. Moreover, cAMP-protein kinase A (PKA)-mediated nuclear β-catenin activity was responsible for the negative function of azoramide on bone formation in favor of adipogenesis. Conclusions: These data provide the first evidence to show that azoramide may serve as an antagonist against GLP-1R in MSC lineage determination. [ABSTRACT FROM AUTHOR]